|
|
Volumn 455, Issue 7217, 2008, Pages 1168-1170
|
|
Pharmaceutical futures: Made in China?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
CENTRAL NERVOUS SYSTEM AGENTS;
GENERIC DRUG;
HEPARIN;
DRUG;
FUTURE PROSPECT;
PHARMACEUTICAL INDUSTRY;
ALZHEIMER DISEASE;
BIOTECHNOLOGY;
CHINA;
CLINICAL PRACTICE;
DRUG COST;
DRUG INDUSTRY;
DRUG RESEARCH;
GENETIC ANALYSIS;
HEALTH CARE PLANNING;
HEALTH PROGRAM;
HEALTH SERVICE;
HUMAN;
INCIDENCE;
MAJOR HISTOCOMPATIBILITY COMPLEX;
MEDICAL DECISION MAKING;
MEDICAL EXPERT;
MEDICAL INSTRUMENTATION;
MULTIPLE SCLEROSIS;
PARKINSON DISEASE;
PRIORITY JOURNAL;
SHORT SURVEY;
ASIA;
CHINA;
EURASIA;
FAR EAST;
|
|
EID: 55249092720
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/4551168a Document Type: Short Survey |
|
Times cited : (10)
|
|
References (0)
|